13F Data
13F filer · CIK 1534261

Casdin Capital, LLC

New York, NY · filing since Q4 2015 · last filing Aug 14, 2026
Reported value
$2.0B
+$677.2M vs prior
Positions
43
New / sold out
6 / 3
Added / reduced
9 / 3
Turnover
8.4%
buys $198.6M · sells $139.3M
Top-10 weight
77.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedGENEDX HOLDINGS CORP+700,000+23.3%+$48.1M
AddedRELAY THERAPEUTICS INC+1,616,666+11.2%+$30.2M
NewPARABILIS MEDICINES INC+645,690–+$17.7M
NewSIONNA THERAPEUTICS INC+400,000–+$17.6M
AddedSCHOLAR ROCK HLDG CORP+315,000+90.0%+$17.3M
AddedGRAIL INC+250,000+108.7%+$17.1M
AddedPERSONALIS INC+950,000+59.4%+$12.7M
NewSAREPTA THERAPEUTICS INC+470,000–+$8.4M
AddedADLAI NORTYE LTD+711,539+132.1%+$8.2M
NewUNIQURE NV+150,000–+$6.9M
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Reduced10X GENOMICS INC-1,225,000-53.8%$-47.0M
ReducedBIOLIFE SOLUTIONS INC-1,302,165-21.9%$-36.8M
ReducedGUARDANT HEALTH INC-130,000-41.3%$-19.5M
Sold outQIAGEN NV-360,000-100.0%$-14.4M
Sold outTEMPUS AI INC-294,127-100.0%$-13.3M
Sold outMOONLAKE IMMUNOTHERAPEUTICS-450,000-100.0%$-8.4M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $113.2MQ1 2016: $87.1MQ2 2016: $100.5MQ3 2016: $123.5MQ4 2016: $121.1MQ1 2017: $169.5MQ2 2017: $270.4MQ3 2017: $354.2MQ4 2017: $410.6MQ1 2018: $568.6MQ2 2018: $715.0MQ3 2018: $822.8MQ4 2018: $584.5MQ1 2019: $910.4MQ2 2019: $1.1BQ3 2019: $966.3MQ4 2019: $1.1BQ1 2020: $942.0MQ2 2020: $1.7BQ3 2020: $2.2BQ4 2020: $3.4BQ1 2021: $3.4BQ2 2021: $3.9BQ3 2021: $4.0BQ4 2021: $3.5BQ1 2022: $2.2BQ2 2022: $1.2BQ3 2022: $1.5BQ4 2022: $1.3BQ1 2023: $1.2BQ2 2023: $1.1BQ3 2023: $903.5MQ4 2023: $1.0BQ1 2024: $1.3BQ2 2024: $1.3BQ3 2024: $1.5BQ4 2024: $1.5BQ1 2025: $1.2BQ2 2025: $1.1BQ3 2025: $1.2BQ4 2025: $1.6BQ1 2026: $1.3BQ2 2026: $2.0B
Q4 2015Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM2,577,333$482.7M24.16%
2RELAY THERAPEUTICS INCCOM16,035,240$300.0M15.02%
3GENEDX HOLDINGS CORPCOM CL A3,707,164$254.5M12.74%
4BIOLIFE SOLUTIONS INCCOM NEW4,655,000$131.5M6.58%
5ILLUMINA INCCOM530,000$93.2M4.66%
6STANDARD BIOTOOLS INCCOM88,783,856$73.0M3.66%
7STRUCTURE THERAPEUTICS INCSPONSORED ADS1,175,000$63.1M3.16%
8DENALI THERAPEUTICS INCCOM2,045,000$52.6M2.63%
9NEUROGENE INCCOM1,545,361$48.6M2.43%
10BEAM THERAPEUTICS INCCOM1,350,000$46.3M2.32%
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.